Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
Taiwan News

Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class ...
Front Porch

Paleontology in Colorado: Local Discoveries from 1877 to Today

Join Jim McKeeman, tour guide and lab preparator at the Morrison Natural History Museum, for an engaging presentation on local paleontological discoveries. Learn about dinosaurs and other ancient ...

Mark Carney set to visit Australia

Canadian Prime Minister Mark Carney will visit Australia next week. It will be his first official visit to the country. He is expected to travel to Sydney and Canberra, where he will be addressing ...